Initiate KOMET-015 Phase 1 trial of ziftomenib with imatinib in advanced GIST
Delivered by the deadline
AI-confirmed · human review in progress Independent AI checks agreed on primary SEC or regulator evidence. Records are now being reviewed by hand, starting with those our customers order.
- Announced
- 5 Feb 2025
- Due
- 30 Jun 2025
- Delivered
- 28 Apr 2025
- Deadline
- Met
- Late
- Not met
- Today
What the company said
“Initiate KOMET-015 Phase 1 trial of ziftomenib in combination with imatinib in patients with advanced GIST 1H 2025”
What we found
Evidence strength B What the grades mean
Kura Oncology announced first patients dosed in the KOMET-015 Phase 1 trial (ziftomenib plus imatinib in advanced GIST) on April 28, 2025, within the 1H 2025 target.
-
B Kura Oncology Reports Fourth Quarter and Full Year 2025 Financial Results Later report shows KOMET-015 enrollment ongoing into 2026
-
B Kura Oncology Reports First Quarter 2025 Financial Results Q1 2025 earnings report reiterating KOMET-015 dosing milestone
-
B Kura Oncology Announces First Patients Dosed in Phase 1 Combination Trial of Ziftomenib for the Treatment of Advanced GIST Press release confirming first patients dosed in KOMET-015 trial
Checked 12 Sep 2026.
Commitment DNA
The structured record of this commitment. Fields the company did not state are left blank rather than guessed.
- Event type
- Clinical milestone
- Indicative materiality
- Medium rules
- Action
- Initiate
How this entry was checked
- Commitment recordedRecorded from the company's filing.
- First checkAn AI model read the company's later filings and recorded the outcome with a quoted passage.
- Second check: agreesA different AI model, Gemini (Google), re-read the evidence without being told the outcome and reached the same answer.
Confirmed. This outcome counts towards the company's Kept Score. How verification works
Are you Kura Oncology, Inc.? You can publish an official statement next to this entry, free. Add a statement.
Is something here wrong or out of date? Companies and readers can ask us to check it. Please bring a link to a public source.
Report an error in this entry Reference: KI-C-2025-KURA-000223 · Corrections policy